PIPELINE

Pipeline details 

[IL2102] (SOS1 inhibitor) A perfect combination partner for …

[IL2102] (SOS1 inhibitor) A perfect combination partner for KRAS inhibitor DescriptionWe have identified potent, selective, orally av…

IL2102   2024

[IL2106] (CDK inhibitor) First-in-class CDK 4/6/12 inhibitor

[IL2106] (CDK inhibitor) First-in-class CDK 4/6/12 inhibitor Description<MoA>We identified first-in-class CDK 4/6/12 inhibitor …

IL2106   2024

[IL2106] CDK 12 inhibitor/Molecular glue/TPD

[IL2106] CDK 12 inhibitor/Molecular glue/TPD DescriptionWe have discovered a novel and potent molecular glue as an emerging therapeut…

IL2106   2024

[IL2112] (CXCR7 agonist) First in class anti-fibrosis for IP…

[IL2112] (CXCR7 agonist) First in class anti-fibrosis for IPF and NASH Description Oral available small molecule chemokine modul…

IL2112   2024

[IL2112] (CXCR7 agonist) First in class Neurodegeneration

[IL2112] (CXCR7 agonist) First in class Neurodegeneration Description Oral available small molecule chemokine modulator for treat…

IL2112]   2024

[IL2401] (DAC) Degrader payloads for ADC

[IL2401] (DAC) Degrader payloads for ADCDescription A novel degrader payload series showed strong anti-cancer activities in various c…

IL2401   2024